Home/Filings/4/0001209191-17-022662
4//SEC Filing

ROCKWELL MEDICAL, INC. 4

Accession 0001209191-17-022662

$RMTICIK 0001041024operating

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 6:40 PM ET

Size

5.3 KB

Accession

0001209191-17-022662

Insider Transaction Report

Form 4
Period: 2017-03-21
Gupta Ajay
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2017-03-21+68,500560,167 total
Footnotes (1)
  • [F1]Performance-based stock grant. This grant vests upon the earliest to occur of any of the following (a) reported net sales of the company in any four consecutive calendar quarters equals or exceeds $100,000,000, (b) the market capitalization of the company is greater than $600,000,000 for ten consecutive trading days, or (c) one year following the date the Centers for Medicare & Medicaid Services assign the company transitional add on reimbursement payment status for the drug product, Triferic.

Issuer

ROCKWELL MEDICAL, INC.

CIK 0001041024

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001041024

Filing Metadata

Form type
4
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 6:40 PM ET
Size
5.3 KB